Drugs that contain Valganciclovir Hydrochloride
1. Valcyte patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9642911 | HOFFMANN LA ROCHE | Pharmaceutical dosage forms comprising valganciclovir hydrochloride |
Dec, 2027
(4 years from now) | |
| US8889109 | HOFFMANN LA ROCHE | Pharmaceutical dosage forms comprising valganciclovir hydrochloride |
Dec, 2027
(4 years from now) | |
Market Authorisation Date: 28 August, 2009
Treatment: NA
Dosage: FOR SOLUTION;ORAL
How can I launch a generic of VALCYTE before it's drug patent expiration?
More Information on Dosage
VALCYTE family patents
